News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Haibin Pharma Announces European Approval for Bulk Antibiotic


12/2/2011 12:45:11 PM

December 2, 2011 -- Shenzhen Haibin Pharma received a EU-GMP certificate from Germany allowing it to sell its meropenem bulk drug in Europe. Meropenem is a broad spectrum antibiotic. Haibin said it is the first China company to be granted European approval for meopenem bulk medicine. Currently, Haibin supplies almost 50% of China’s meropenem needs, and it exports to many areas of the world as well. Haibin is a subsidiary of Joincare Pharma. More details....

Stock Symbol: (SHA: 600380)


Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES